Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-060539
Filing Date
2013-11-12
Accepted
2013-11-12 16:32:42
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v359050_10q.htm 10-Q 776643
2 EXHIBIT 10.1 v359050_ex10-1.htm EX-10.1 235046
3 EXHIBIT 10.2 v359050_ex10-2.htm EX-10.2 42594
4 EXHIBIT 31.1 v359050_ex31-1.htm EX-31.1 24832
5 EXHIBIT 32.1 v359050_ex32-1.htm EX-32.1 10387
  Complete submission text file 0001144204-13-060539.txt   4663958

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20130930.xml EX-101.INS 578534
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20130930.xsd EX-101.SCH 39153
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20130930_cal.xml EX-101.CAL 42798
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20130930_def.xml EX-101.DEF 184441
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20130930_lab.xml EX-101.LAB 264264
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20130930_pre.xml EX-101.PRE 226375
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12957 | Film No.: 131210594
SIC: 2836 Biological Products, (No Diagnostic Substances)